The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 281

More Articles from The Primary Care Companion for CNS Disorders

PCC
Article

Bipolar Depression: Specific Treatments

June 1, 1998

PCC
Article

Selecting an Antidepressant by Using Mechanism of Action to Enhance Efficacy and Avoid Side Effects

May 1, 1998

PCC
Article

Depression With Anger Attacks

April 1, 1998

PCC
Article

Anxious Depression

March 1, 1998

,
PCC
Article

Course and Treatment of Atypical Depression

February 1, 1998

, , , et al
PCC
Publisher’s Note

A New Chapter for The Primary Care Companion

December 15, 1997

news

Similar Outcomes With 2-Week and 4-Week Tapers to Xanomeline-Trospium

September 10, 2026

Xanomeline-trospium 2-week and 4-week taper schedules show similar discontinuation rates and tolerability in stable schizophrenia; 86% reached target dose.
news

Xanomeline-Trospium and EPS: Low Rates Across EMERGENT, Limited Evidence

September 10, 2026

Xanomeline-trospium EPS rates were low across EMERGENT-1, -2, and -3, but trial limitations, attrition, and no comparator data leave the motor safety profile incompletely defined.
JCP
Voice of the Patient
Commentary

Voice of the Patient

September 9, 2026

Discusses a recent study by Bayrampour et al of the use of speech features for prediction of MDD and GAD during pregnancy.
JCP
Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages
Original Research

Utilizing a Smartphone Application for Perinatal Depression Screening and Care Linkages

September 9, 2026

The prevalence of probable perinatal depression was comparable to that in US women, demonstrating the app’s ability to identify perinatal depression.
, , , et al
JCP
Using Speech to Predict MDD and GAD During Pregnancy
Original Research

Using Speech to Predict MDD and GAD During Pregnancy

September 9, 2026

Influential speech features for prediction of MDD and GAD during pregnancy were similar to those in the general population.
, , , et al
JCP
The Regulatory Maze of Ketamine and Psychedelics with Benjamin Brody, MD
Podcast

The Regulatory Maze of Ketamine and Psychedelics with Benjamin Brody, MD

September 8, 2026

Benjamin Brody, MD, discusses ketamine’s REMS-regulated future, esketamine safety, dysphoric dissociation, and what psilocybin approval means for psychiatry.
,

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe